Arsanis, Inc.

Home » Arsanis, Inc.

IPO

Arsanis, Inc.

They are a clinical-stage biopharmaceutical company focused on applying monoclonal antibody immunotherapies to address serious infectious diseases.

Symbol

ASNS

Price Range
$15.00 - $17.00

Anticipated Shares
4,000,000

Effective Date
November 16, 2017

Underwriters
Citigroup, Cowen, Piper Jaffray

To view the prospectus for Arsanis, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253